AB Hassle et al. v. Genpharm Inc. et al., (2003) 243 F.T.R. 6 (FC)

This document cites

• Bull (David) Laboratories (Canada) Inc. v. Pharmacia Inc. et al., (1994) 176 N.R. 48 (FCA)
• R. v. L.T.C., (1995) 192 N.R. 80 (Motion)
• R. v. Abbey, (1982) 43 N.R. 30 (SCC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2002) 225 F.T.R. 1 (TD)
• Apotex Inc. v. Canada (Minister of National Health and Welfare) et al., (1997) 219 N.R. 151 (FCA)



See all quotations

• Novartis AG et al. v. Apotex Inc. et al., (2002) 298 N.R. 348 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2000) 262 N.R. 137 (FCA)
• AB Hassle v. Can., (2000) 256 N.R. 172 (FCA)
• Airseal Controls Inc. v. M & I Heat Transfer Products Ltd., (1997) 220 N.R. 58 (FCA)
• Vancouver Island Peace Soc. v. Can., (1995) 179 N.R. 106 (FCA)
• Vancouver Island Peace Society et al. v. Canada (Minister of National Defence) et al., (1993) 64 F.T.R. 127 (TD)
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Canamould Extrusions Ltd. et al. v. Driangle Inc., (2003) 229 F.T.R. 104 (TD)
• Bayer AG et al. v. Apotex Inc. et al., 2003 FC 1199
• Apotex Inc. v. Wellcome Fdn., (1998) 145 F.T.R. 161 (TD)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Procter & Gamble Pharmaceuticals Canada Inc. et al. v. Canada (Minister of Health) et al., 2002 FCA 290
• Bayer Aktiengesellschaft et al. v. Apotex Inc., (1998) 113 O.A.C. 1 (CA)
• Mahurkar v. Vas-Cath of Canada Ltd. and Gambro Canada Ltd., (1988) 16 F.T.R. 48 (TD)
• Procter & Gamble Co. v. Kimberly-Clark of Canada Ltd. (No. 4), (1991) 49 F.T.R. 31 (TD)
• Dableh v. Ontario Hydro, (1996) 199 N.R. 57 (FCA)
• R. v. Gibb (B.R.), (1999) 239 N.R. 200 (Motion)
• R. v. Mohan, (1994) 71 O.A.C. 241 (SCC)
• Illinois Tool Works Inc. et al. v. Cobra Anchors Co., (2003) 312 N.R. 184 (FCA)
• GlaxoSmithKline Inc. et al. v. Genpharm Inc. et al., (2003) 241 F.T.R. 42 (FC)
• Bristol-Myers Squibb Canada Inc. v. Canada (Attorney General) et al., (2001) 266 N.R. 141 (FCA)
• AB Hassle et al. v. Apotex Inc. et al., (2003) 312 N.R. 288 (FCA)
• SmithKline Beecham Pharma Inc. et al. v. Apotex Inc. et al., 2002 FCA 216
• Farbwerke Hoechst Aktiengesellschaf v. Halocarbon (Ontario) Ltd. and Halocarbon Products Corp., (1979) 27 N.R. 582 (SCC)
• Novartis Pharmaceuticals Canada Inc. et al. v. Abbott Laboratories Ltd. et al., (2000) 258 N.R. 105 (FCA)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2001) 266 N.R. 371 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Diversified Products Corp. and Brown Fitzpatrick Lloyd Patent Ltd. v. Tye-Sil Corp., (1991) 125 N.R. 218 (FCA)